Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

screen_shot_2012-06-08_at_14

New COO for Lonza Life Science Ingredients

June 8, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Beat In-Albon, COO, Lonza

Lonza has appointed Beat In-Albon as chief operating officer of its Life Science Ingredients sector. In-Albon, 60, becomes a member …
Appointment
John Lechleiter

Lechleiter wants policy that spurs innovation

June 8, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Lechleiter, Obama, PhRMA, US, heathcare, lilly

Lilly’s leader is calling on governments to take the long-term view when it comes to healthcare policy. John Lechleiter who …
News

Reducing Timelines Through Strategic Outsourcing

June 7, 2012 Research and Development

Frank Lis, Vice President & General Manager, Clinical Supply Services, explores the general effects brought on by the consolidation of …
Feature
Thought Leadership
RoActemra image

RoActemra superior to Humira as single-agent therapy

June 7, 2012 Research and Development, Sales and Marketing Humira, Orencia, RA, RoActemra, Roche. ADACTA

Roche’s RoActemra (tocilizumab) is more effective in treating rheumatoid arthritis as a single agent than market leader Humira, a new …
News

Former Teva president joins Sun Pharma

June 7, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Sun Pharma, Teva, generics, manufacturing

Sun Pharma has appointed Israel Makov as its new chairman of the board. Makov is the former president and chief …
Appointment
ann_judge_2

Shire makes two senior appointments

June 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Colpman, Judge, Shire

Shire has announced the promotion of David Colpman and Ann Judge (pictured) as two senior leaders within the firm.  Colpman, …
Appointment
screen_shot_2012-06-06_at_10

William Kaelin Jr elected to Lilly board

June 6, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Kaelin, lilly

Eli Lilly has elected William Kaelin Jr to its board of directors. Dr Kaelin, 54, is a Professor in the Department of …
Appointment

Merck Serono staff may strike over Geneva HQ closure

June 6, 2012 Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D

Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …
News
ASCO

Herceptin successor impresses at ASCO

June 6, 2012 Research and Development, Sales and Marketing ASCO, Cancer, EMILIA, FDA, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug T-DM1 has impressed at this year’s ASCO conference in Chicago. The trial showed it …
News
Bristol-Myers Squibb

BMS establishes cancer vaccine network

June 1, 2012 Research and Development, Sales and Marketing

Bristol-Myers Squibb has formed a network of ten institutions to advance work on using the body’s own immune system to …
News

ROCK medical communications appoints two new account managers

June 1, 2012 Medical Communications, Research and Development, Sales and Marketing ROCK, medical communications, pharma appointment

ROCK medical communications has appointed two new team members: Suzanne Smith and Nicola Wood. Suzanne joins from Chameleon Communications, where …
Appointment

Boehringer appoints new executive director of Consumer Healthcare Marketing

May 31, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim has announced the appointment of Ross Ullman as the executive director marketing of the Consumer Healthcare division.  In …
Appointment

Pharma relieved as Senate backs FDA fees

May 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing FDA, PDUFA, PhRMA, US

The US Senate has approved a law that will continue to allow pharma firms to help fund the FDA.  The …
News

Photo story: GSK’s 2012 legacy

May 30, 2012 Research and Development Andrew Witty, GSK, Olympics 2012

Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …
Feature

GSK starts combination trial for melanoma

May 30, 2012 Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma

GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs.  The firm will combine dabrafenib, its …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026